NuGen Medical Devices Inc. NGMDF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -79.44% | -70.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -79.44% | -70.20% | |||
| Cost of Revenue | -78.48% | -78.36% | |||
| Gross Profit | -80.20% | -57.74% | |||
| SG&A Expenses | -5.93% | 3.83% | |||
| Depreciation & Amortization | -84.93% | -15.40% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -17.31% | -2.47% | |||
| Operating Income | 16.02% | -2.31% | |||
| Income Before Tax | 39.09% | 67.94% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.06% | 68.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.06% | 68.24% | |||
| EBIT | 16.02% | -2.31% | |||
| EBITDA | 4.20% | -5.90% | |||
| EPS Basic | 38.46% | 68.29% | |||
| Normalized Basic EPS | 39.39% | 63.33% | |||
| EPS Diluted | 38.46% | 68.29% | |||
| Normalized Diluted EPS | 39.39% | 63.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||